Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models ; volume:137 ; number:3 ; day:5 ; month:2 ; year:2019 ; pages:379-395 ; date:3.2019
Acta neuropathologica ; 137, Heft 3 (5.2.2019), 379-395, 3.2019
- Urheber
-
Veys, Lien
Vandenabeele, Marjan
Ortuño-Lizarán, Isabel
Baekelandt, Veerle
Cuenca, Nicolás
Moons, Lieve
De Groef, Lies
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00401-018-01956-z
- URN
-
urn:nbn:de:101:1-2019032619581393934355
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Veys, Lien
- Vandenabeele, Marjan
- Ortuño-Lizarán, Isabel
- Baekelandt, Veerle
- Cuenca, Nicolás
- Moons, Lieve
- De Groef, Lies
- SpringerLink (Online service)
Ähnliche Objekte (12)
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Emotional behavior of aged A53T α-Synuclein Parkinson mice
Models of α-synuclein aggregation in Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease